(Acquired) Leading D2C brand specializing in adaptogens for the thriving $8 billion LATAM health market, experiencing consistent +20% MoM growth. Umi Labs harnesses the potential of adaptogens to optimize well-being.
Client
Leading D2C brand specializing in adaptogens for the thriving $8 billion LATAM health market, experiencing consistent +20% MoM growth. Umi Labs harnesses the potential of adaptogens to optimize well-being.
Year
2021
Location
LATAM